Ron Menezes , , , President and Chief Executive Officer

View bioHide bio

Ron Menezes joined Sientra in November 2020 as President and Chief Executive Officer. Ron’s most recent experience includes serving as President and General Manager for Almirall U.S. – Dermatology, where he led exceptional growth and profitability improvements, returning the U.S. division to profitability. Ron was also part of the team that successfully acquired Allergan’s dermatology assets in 2018. In 2019, he led the launch of a new molecule for the treatment of acne that far exceeded revenue goals by strategically focusing on improving patients’ access to the product. Prior to Almirall, Ron was the Vice President of Sales and Marketing for Dermatology at Allergan, leading the team to more than 20% yearly growth between 2013 and 2015. The growth was driven by increased direct-to-consumer advertising and expanding the promotion of a 20-year-old topical product for acne. As a head of sales for SkinMedica, Latisse and Medical Dermatology, Ron was part of the commercial team that successfully launched a new direct-to-physician sunscreen product. While at SkinMedica, he focused on expanding national accounts that were responsible for driving most of the growth in 2015. Ron has also held key leadership responsibilities at Abbott, Astellas Pharma – U.S., Pfizer and Eli Lilly. Ron holds a B.S. in International Business from Brigham Young University and earned a certificate in Health Care Management from the University of Utah.

Oliver Bennett , , , General Council and Chief Compliance Officer

View bioHide bio

Oliver Bennett joined Sientra in 2015, first as outside counsel and then as general counsel to the company, prior to becoming General Counsel and Vice President for Compliance and Legal in 2018. Oliver brings with him almost two decades of experience in counseling medical device and life science companies in complex and high stakes legal issues. Prior to joining Sientra, he practiced law at a number of premier firms where he was at the cutting edge of legal practice representing clients in ground-breaking cases that have helped shape US law. Most recently, Oliver was a partner at Kirkland & Ellis LLP. Before that, he was Of Counsel at Kaye Scholer LLP (now Arnold White Kaye Scholer LLP), and an associate at Latham & Watkins, LLP and Clifford Chance US LLP. Oliver received a Master in Laws degree from Harvard Law School where he was also a Fulbright Scholar, and Bachelor of Laws and Bachelor of Arts degrees from Griffith University in Brisbane, Australia.

Deborah Bettencourt , , , Vice President, Human Resources & Corporate Administration

View bioHide bio

Deborah Bettencourt joined Sientra in 2007 and has over 25 years of experience in corporate administration within the medical device industry. Deborah began her professional career at Inamed Corporation (currently Allergan Medical) where she was an integral part of global information technology implementations, business acquisitions, system and process integrations and international manufacturing expansions. She is a Society for Human Resource Management Certified Professional (SHRM-CP) and holds a BA in Psychology from the University of California Santa Barbara. Deborah currently serves on the UCSB Alumni Council – Department of Psychological & Brain Sciences.

Dan Carlisle , , , Vice President, Innovation & Product Development, Breast Products

View bioHide bio

Dan Carlisle joined Sientra in 2007 and has nearly 30 years of innovative product design and development experience as well as technical expertise in the aesthetic/surgical market. Prior to joining Sientra, Dan was Senior Director, Technical Marketing at Inamed Corporation (currently Allergan Medical) where he was responsible for designing, refining and improving new products for the global aesthetic market. Additionally, he served as Director of the internationally recognized Inamed Academy™ (currently Allergan Academy®), a global education and training platform for surgeons. He is named inventor or co-inventor on numerous patents in the aesthetic plastic surgery field. Before Inamed, Dan held various management positions at Silimed Corporation based out of Brazil and at McGhan Medical. He holds a BA in Art from California State University at Northridge.

Kirk Gunhus , , , Senior Vice President of Worldwide Sales

View bioHide bio

Kirk Gunhus joined Sientra in 2018 as Vice President of International Sales for miraDry. In his current role, Kirk now oversees worldwide sales for both the miraDry and Breast Product segments of the company. Kirk brings over 20 years of commercial experience in the health care and device industry, most recently serving as Vice President of APAC at ZELTIQ Aesthetics, before joining Sientra. Kirk has a track record of success in the aesthetic capital market business and has demonstrated exceptional leadership in his career. While at ZELTIQ, he led Europe and Asia Pacific Operations to over $30M in revenue and organized expansion in several APAC and European countries. Prior to ZELTIQ, Kirk held numerous sales roles at Medicis Health, selling Restylane, Perlane and Dysport and Cibia Vision, a subsidiary of Novartis. Kirk has a Bachelor’s degree in Arts from North Central University in Minneapolis, Minnesota and a Masters of Leadership degree from Bellevue University, Nebraska.

Jeff Jones , , , Vice President, Operations

View bioHide bio

Jeff Jones joined Sientra in 2019. He brings over 30 years of operations and quality experience with both medical device start-ups and Fortune 500 companies to Sientra. Most recently, Jeff was Vice President of Quality and Commercial Operations at Earlens, a medical device startup that makes direct-drive hearing devices that sit directly on the eardrum. Earlier in his career, Jeff served as Vice President, R&D/Operations at Johnson and Johnson, Vice President, Operations at Boston Scientific, and various Senior Management positions at six San Francisco Bay Area startups. He was also the recipient of the 2010 Johnson & Johnson Worldwide Supply Chain Collaboration Excellence Award where he led the integration of manufacturing operations from Acclarent into the Johnson and Johnson global supply chain. Jeff holds a B.S. in Engineering from the U.S. Military Academy at West Point and a MBA in Management from Golden Gate University. He spent six years in the US Army on active duty flying helicopters and holds an FDA commercial instrument helicopter rating.

JoAnn Kuhne , , , Vice President of Regulatory Affairs, Quality Assurance & Clinical Operations

View bioHide bio

JoAnn Kuhne joined Sientra in 2006 and has more than twenty years of global regulatory and clinical experience. Prior to joining Sientra, JoAnn served as Senior Director, Regulatory Affairs at Inamed Corporation (now Allergan Medical) where she was instrumental in the company’s efforts to obtain PMA approval for the company’s silicone gel breast implants. Before Inamed, JoAnn was Director of Regulatory & Clinical Affairs at Medtronic PS Medical, leading the company’s global regulatory and clinical efforts for its neurosurgical implants. Preceding her career at Medtronic PS Medical and Inamed, she spent several years in the orthopedic implant industry as Manager of Regulatory Affairs for Smith and Nephew Orthopedics and Intermedics Orthopedics. JoAnn received her BSN from Northern Michigan University in Marquette, Michigan and an MSN from the University of North Carolina at Chapel Hill. She is a member of the Sigma Theta Tau International Honor Society and is board certified in Regulatory Affairs. JoAnn is an active volunteer at the Santa Ynez Valley Therapeutic Riding Center and is a sponsor for Threshold Ministries and Impact 2818.

Valerie Miller , , , Interim Chief Financial Officer and Vice President Corporate Controller

View bioHide bio

Valerie Miller joined Sientra in 2017. She has over 20 years of financial management experience in both public and private healthcare and technology companies. Valerie has held a variety of financial executive level positions. Most recently, she held senior financial positions at The Trade Desk, Inc, which went public in 2016 and at lynda.com (which was acquired by LinkedIn in 2015). Prior to that, Ms. Miller spent five years as VP Controller at Mentor Corporation (now Johnson & Johnson). She was also VP Corporate Controller at QAD, Inc., a public software company. Earlier in her career, Valerie was in financial management at Allergan, Inc. She is a CPA and received a Bachelor of Arts in Business Economics with an emphasis in Accounting from the University of California, Santa Barbara.

Kim Porter , , , Vice President, Information Technology

View bioHide bio

Kim Porter joined Sientra in 2018. She brings with her over 20 years of Information Technology experience with large government and public companies. Kim most recently served as Deputy Chief Information Officer at the County of Ventura, an award winning digital government agency. Prior to the county, she served as a technical leader at Amgen, where she held various roles in the global information technology organization. Kim received a Bachelor’s of Science degree from Excelsior College while serving in the United States Army.

Lisa Rosas , , , Vice President, Marketing

View bioHide bio

Lisa Rosas joined Sientra in 2018. She brings over 20 years of marketing leadership in a wide range of aesthetics businesses. Prior to joining Sientra, Lisa was Vice President of Marketing at Obalon Therapeutics, which went public in 2016, and ZELTIQ Aesthetics, where she played a critical role in establishing category superiority for the CoolSculpting brand prior to the acquisition by Allergan in 2017. Lisa also held leadership positions at Medicis and Allergan previously. Lisa has been awarded a BA in communications from the University of Wisconsin and an MBA from Graziadio School of Business and Management, Pepperdine University. She has also done graduate work at the University Adolfo Ibañez in Chile as well as the University of Oxford in England.

Nasdaq: SIEN

Stock Quote: NASD

$6.81 -0.01
Volume 163,957
Previous Close 6.82
Intraday High 6.95
Intraday Low 6.63
Pricing delayed 20 minutes
Price Change % Change -0.15% 52 Week High 8.93 52 Week Low 1.65 Today's Open 6.81 Apr 22, 2021 12:44 PM

Investor Contact

Sientra Investor Relations
805-679-8885